BackOther Urogenital Infections: Microbial Pathogens, Diagnosis, and Treatment
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Other Urogenital Infections
Overview
Urogenital infections are caused by a variety of microbial pathogens, including viruses, fungi, and protozoa. These infections can affect the urinary and reproductive tracts, leading to a range of symptoms and complications. Understanding the characteristics, transmission, diagnosis, and treatment of these pathogens is essential for effective clinical management and prevention.
Viruses Associated with Urogenital Infections
Herpes Simplex Virus 2 (HSV-2)
HSV-2 is a DNA virus primarily responsible for genital herpes. It establishes lifelong infection and is transmitted through direct contact.
Transmission: Direct contact with infected skin or mucous membranes.
Lifelong infection: Virus remains latent in nerve cells and can reactivate, causing recurrent outbreaks.
Main symptom: Skin lesions (herpes blisters) that are clustered, fluid-filled, and have a red base.
Diagnosis: Usually clinical; serology for antibodies can confirm infection.
Prevalence: HSV-1 (oral) ~48%; HSV-2 (genital) ~12% in the US population.
Treatment: Antivirals (e.g., acyclovir) can shorten outbreaks and reduce transmission risk but do not cure the infection.
Neonatal Herpes: Can be transferred to newborns during delivery, leading to severe complications (skin, eye, mouth, CNS, disseminated infection).
Example: A patient with recurrent genital sores may be diagnosed with HSV-2 and managed with suppressive antiviral therapy.
Human Papilloma Viruses (HPV)
HPV is a group of DNA viruses that infect epithelial cells, causing warts and, in some cases, cancer.
Symptoms: Papilloma (warts), often asymptomatic; warts may be single or clustered, often raised.
Transmission: Direct skin-to-skin contact, including sexual contact.
Prevalence: ~40% of US population has HPV; ~20% have high-risk strains associated with cancer.
Oncogenic potential: Some HPV types produce proteins that disrupt cell cycle checkpoints, leading to cancer (e.g., cervical, anal, oropharyngeal).
Prevention: HPV vaccine (Gardasil) recommended at age 11-12, available up to age 45; composed of empty virus capsid (viral-like particle).
Screening: Pap smears for cervical cancer starting at age 21; early detection improves prognosis.
Example: Routine Pap smear detects abnormal cervical cells, prompting further investigation for HPV-related changes.
Fungal Pathogens
Candida spp. (Yeast Infections)
Candida albicans and Candida glabrata are opportunistic fungi that are part of the normal microbiome but can cause vulvovaginal candidiasis when overgrown.
Characteristics: Yeast, forms pseudohyphae during infection.
Pathogenesis: Overgrowth due to microbiome disruption (e.g., loss of Lactobacillus protection).
Risk factors: Antibiotic use, pregnancy/hormonal changes, immunocompromised state, unmanaged diabetes.
Symptoms: Skin redness/rash, itching, burning, pain, discharge, lumpy white patches.
Prevalence: ~7 million women per year in the US; ~350,000 with recurrent infections.
Diagnosis: Wet mount microscopy, PCR-based detection; about 1/3 self-diagnosed, most confirmed by exam and tests.
Treatment: OTC antifungals (miconazole), prescription azoles (clotrimazole, fluconazole).
Prevention: Maintain healthy microbiome, avoid triggers, use condoms, avoid certain hygiene products, wear breathable clothing.
Example: A patient with vaginal itching and discharge is diagnosed with vulvovaginal candidiasis and treated with oral fluconazole.
Protozoan Pathogens
Trichomonas vaginalis
Trichomonas vaginalis is a flagellated, anaerobic protozoan parasite causing trichomoniasis, a common sexually transmitted infection.
Life cycle: Only one trophozoite form; replicates in urethral opening and/or vagina; no cyst stage.
Transmission: Direct sexual contact.
Symptoms: Incubation 5-28 days; 70% asymptomatic. Penile symptoms: burning, itching, discharge. Vaginal symptoms: itching, burning, pain, frothy/foul-smelling discharge.
Prevalence: Most common protozoan infection in industrialized nations; >2 million cases annually in the USA.
Diagnosis: Wet mount microscopy (motile organisms), direct fluorescent antibody staining, culture (most sensitive, 3-7 days).
Treatment: Metronidazole (women: 7 days; men: single dose); treat partners; retest in 3 months for recurrence.
Example: A patient with frothy vaginal discharge and itching is diagnosed with trichomoniasis and treated with metronidazole.
Comparative Table: Urogenital Pathogens
Pathogen | Type | Main Symptoms | Diagnosis | Treatment |
|---|---|---|---|---|
HSV-2 | Virus | Genital skin lesions, pain | Clinical, serology | Antivirals (acyclovir) |
HPV | Virus | Genital warts, asymptomatic, cancer risk | Pap smear, clinical | Vaccine, removal/ablation |
Candida spp. | Fungus | Itching, discharge, rash | Microscopy, PCR | Azole antifungals |
Trichomonas vaginalis | Protozoan | Itching, burning, frothy discharge | Microscopy, culture | Metronidazole |
Practice Diagnosis Questions
Clinical Application
Case 1: Sexually-active patient with abnormal vaginal discharge, burning, and pain: Consider Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Candida spp., and Gardnerella vaginalis.
Case 2: Non-sexually active 13-year-old with vulvar redness, itching, burning, pain, and discharge: Most likely Candida spp. and Gardnerella vaginalis.
Case 3: 70-year-old woman with pain and burning when peeing, frequent urination, and lower abdominal discomfort, no vulvar symptoms: Most likely urinary tract infection (UPEC).
Case 4: Preventative measures for recurrent UTI: Hydration, proper hygiene, post-coital urination, and avoiding irritants.
Case 5: 22-year-old male STI screening: Possible detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, HSV-2, HPV, and Treponema pallidum.
Use nites and paper to explain reasoning or type under the slide.
Key Terms and Definitions
Opportunistic pathogen: Microbe that causes disease primarily in immunocompromised hosts or when normal microbiota is disrupted.
Pseudohyphae: Elongated yeast cells formed by Candida during infection.
Trophozoite: Active, feeding stage of protozoan parasites.
Latent infection: Persistent infection with periods of dormancy and reactivation.
Oncogenic virus: Virus capable of causing cancer (e.g., HPV).
Formulas and Equations
Prevalence Calculation:
Additional info: The notes also reference other urogenital pathogens (e.g., Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum, Gardnerella vaginalis, UPEC), but detailed coverage is focused on HSV-2, HPV, Candida spp., and Trichomonas vaginalis.